Bgm BGM
NASDAQ BGM
$0.26 +0.01 (+4.38%)
As of: Sep 30, 2026 · 3:59 PM EDT

Bgm (BGM) Receivables - Other (2019 - 2025)

Updated

Bgm (BGM) recorded Receivables - Other of $349,314 in fiscal Q4 2025 (quarter ended Sep 30, 2025), up 81.6% from $192,387 a year earlier.

Analysis

Bgm (BGM) Receivables - Other (2019 - 2025) Analysis & Trends

Starting with fiscal Q4 2019, Bgm's Receivables - Other history includes 11 quarters.

  • Annual Receivables - Other has a five-year compound annual growth rate of 63.4% (FY2020 to FY2025).
  • Across earlier fiscal years, Receivables - Other came in at $192,387 in FY2024 (-22.3%), $247,481 in FY2023 (-83.2%), $1.47 million in FY2022 and $17,318 in FY2021 (-42.2%).
  • Quarterly Receivables - Other has ranged from -$16,103 in fiscal Q2 2021 to $1.47 million in fiscal Q4 2022 over the past five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn
10 Bgm 28.32 Mn -4,800.01 Bn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 349,314.00
Mar 31, 2025 377,110.00
Sep 30, 2024 192,387.00
Mar 31, 2024 129,612.00
Sep 30, 2023 247,481.00
Sep 30, 2022 1.47 Mn
Mar 31, 2022 9,802.00
Sep 30, 2021 17,318.00
Mar 31, 2021 -16,103.00
Sep 30, 2020 29,973.00
Sep 30, 2019 2,254.00
API Access

Bgm Receivables - Other API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-other&ticker=BGM&period=max&api_key=YOUR_API_KEY